Aptevo Therapeutics
APVO
APVO
6 hedge funds and large institutions have $35.9K invested in Aptevo Therapeutics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Holders
6
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$30.5K | |
| 2 | +$3.14K | |
| 3 | +$1.69K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$4 |
Top Sellers
| 1 | -$12.2K | |
| 2 | -$3.25K | |
| 3 | -$339 | |
| 4 |
Morgan Stanley
New York
|
-$4 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BC
1
Birchview Capital
Burlington,
Vermont
| $30.5K |
|
|||
|
TRCT
2
Tower Research Capital (TRC)
New York
| $3.64K |
|
|||
|
SS
3
SBI Securities
Tokyo,
Japan
| $1.79K |
|
|||
4
Bank of America
Charlotte,
North Carolina
| $9 |
|
|||
|
5
Osaic Holdings
Scottsdale,
Arizona
| $4 |
|
|||
6
BlackRock
New York
| $3 |
|
|||
7
Geode Capital Management
Boston,
Massachusetts
| – |
|
|||
|
CS
8
Clear Street
New York
| – |
|
|||
|
9
Morgan Stanley
New York
| – |
|